Phillips Medisize will be exhibiting at Drug Delivery to the Lungs (DDL) 2026, taking place 9-11 December 2026 in Edinburgh, Scotland. We look forward to connecting with colleagues across the inhalation community and sharing the latest developments in inhaled drug delivery.
Our team will be presenting on topics including:
- High-Concentration Immunoglobulin G Delivery Using the FOX™ Vibrating Mesh Nebuliser
Josh Newman, Team Leader
- Impact of Device Resistance and Inhalation Orientation on the Delivered Dose of an Open-Inhale-Close Dry Powder Inhaler Being Used for a Systemic Drug Delivery Application
Murat Ali, Associate Director — Device Development
- Delivery System Options for Inhaled Spray-Dried GLP-1 Peptides: A Comparison of Stability Profiles for Capsule Versus Blister Devices
Zachary Coe, Inhalation Development Specialist
In addition to the above, Kerry Carr, Pharmaceutical Development Team Leader, is a co-author on a collaborative research presentation:
- Towards Standardised Compendial Testing of Nasal Products: Multi-Laboratory Evaluation of the Kiel Nasal Inlet for Assessment of the %<10 µm Fraction
Visit us at booth 166 to discuss inhalation product development, device technologies and manufacturing solutions for inhaled therapies. Our team will be available throughout the conference to explore challenges and opportunities across formulation, device and combination product development.
Planning to Attend DDL?
If you’d like to meet with the Phillips Medisize team during the conference, complete our contact us form and we’ll arrange a conversation.
Our Inhalation CDMO Capabilities
Phillips Medisize offers formulation, device design and combination product development, as well as manufacturing services to support the growing global need for inhalation and nasal therapies. Our expertise includes small molecules, biologics, complex combinations and generic products for pMDI, DPI, nasal inhaler and nebulization devices.
Want to Connect Now?
Whether you’re exploring formulation, device or manufacturing considerations, we’d welcome the opportunity to connect. Complete our contact us form and a member of our team will be in touch.